Entera Bio Ltd.
NASDAQ:ENTX
1.83 (USD) • At close October 17, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 0 | 0.134 | 0.571 | 0.365 | 0.236 | 0.5 | 0 | 0 | 0 |
| Cost of Revenue
| 0.056 | 0.101 | 0.373 | 0.209 | 0.21 | 0 | 0.043 | 0.035 | 0.028 |
| Gross Profit
| -0.056 | 0.033 | 0.198 | 0.156 | 0.026 | 0.5 | -0.043 | -0.035 | -0.028 |
| Gross Profit Ratio
| 0 | 0.246 | 0.347 | 0.427 | 0.11 | 1 | 0 | 0 | 0 |
| Reseach & Development Expenses
| 4.51 | 5.848 | 6.771 | 6.398 | 7.199 | 8.518 | 2.768 | 2.648 | 2.115 |
| General & Administrative Expenses
| 4.43 | 7.253 | 5.69 | 4.891 | 4.281 | 2.843 | 8.575 | 2.719 | 1.586 |
| Selling & Marketing Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 4.43 | 7.253 | 5.69 | 4.891 | 4.281 | 2.843 | 8.575 | 2.719 | 1.586 |
| Other Expenses
| 0 | -0.051 | -0.046 | 1.237 | 0.743 | 0.523 | 0 | 0 | 0 |
| Operating Expenses
| 8.86 | 13.05 | 12.415 | 11.289 | 11.48 | 11.361 | 11.343 | 5.367 | 3.701 |
| Operating Income
| -8.891 | -13.017 | -12.217 | -11.133 | -11.454 | -10.861 | 11.343 | -5.367 | -3.701 |
| Operating Income Ratio
| 0 | -97.142 | -21.396 | -30.501 | -48.534 | -21.722 | 0 | 0 | 0 |
| Total Other Income Expenses Net
| 0.031 | 0.083 | -0.029 | 1.17 | 0.659 | 0.523 | 0.146 | 4.168 | -0.581 |
| Income Before Tax
| -8.86 | -12.934 | -12.246 | -9.963 | -10.795 | -10.304 | -11.197 | -1.199 | -4.282 |
| Income Before Tax Ratio
| 0 | -96.522 | -21.447 | -27.296 | -45.742 | -20.608 | 0 | 0 | 0 |
| Income Tax Expense
| 0.029 | 0.137 | -0.059 | 0.02 | 0.084 | 0.557 | -0.146 | 0 | 0 |
| Net Income
| -8.889 | -13.071 | -12.187 | -9.983 | -10.879 | -10.304 | -11.197 | -1.199 | -4.282 |
| Net Income Ratio
| 0 | -97.545 | -21.343 | -27.351 | -46.097 | -20.608 | 0 | 0 | 0 |
| EPS
| -0.31 | -0.45 | -0.47 | -0.54 | -0.9 | -1.3 | -1.31 | -0.14 | -0.36 |
| EPS Diluted
| -0.31 | -0.45 | -0.47 | -0.54 | -0.9 | -1.29 | -0.94 | -0.1 | -0.36 |
| EBITDA
| -8.835 | -13.017 | -12.164 | -11.133 | -11.216 | -10.807 | -11.446 | -5.332 | -3.673 |
| EBITDA Ratio
| 0 | -97.142 | -21.303 | -30.501 | -47.525 | -21.614 | 0 | 0 | 0 |